NFAT transcription factors: From cell cycle to tumor development

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 3, 2005, Pages 335-344

  Viola, J P B ^a   Carvalho, L D S ^a   Fonseca, B P F ^a   Teixeira, L K ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Cancer; Cell cycle; Cell differentiation; Gene expression; NFAT

Indexed keywords

CALCIUM ION; CYTOKINE; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; CALCIUM CELL LEVEL; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELL TYPE; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVIEW;

EID: 16844382568     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000300003     Document Type: Review

References (60)

1. Rao A, Luo C & Hogan PG (1997). Transcription factors of the NFAT family: regulation and function. Annual Review of Immunology, 15: 707-747.
2. Hernández GL, Volpert OV, Íñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M & Redondo JM (2001). Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. Journal of Experimental Medicine, 193: 607-620.
3. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MBF, Barcinski MA & Viola JPB (2002). NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB Journal 16: 1940-1942.
4. Baksh S, Widlund HB, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, DeCaprio JA, Modiano JF & Burakoff SJ (2002). NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Molecular Cell, 10: 1071-1081.
5. Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M & Crabtree GR (2003). Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell, 113: 657-670.
6. Neal JW & Clipstone NA (2003). A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. Journal of Biological Chemistry, 278: 17246-17254.
7. Zaichuk TA, Shroff EH, Emmanuel R, Filleur S, Nelius T & Volpert O (2004). Nuclear factor of activated T cells balances angiogenesis activation and inhibition. Journal of Experimental Medicine, 199: 1513-1522.
8. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA & Crabtree GR (1988). Identification of a putative regulator of early T cell activation genes. Science, 241: 202-205.
9. Macian F, Lopez-Rodriguez C & Rao A (2001). Partners in transcription: NFAT and AP-1. Oncogene, 20: 2476-2489.
10. McCaffrey PG, Luo C, Kerppola TK et al. (1993) Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750-754.
11. Luo C, Burgeon E, Carew JA, Badalian TM, McCaffrey PG, Lane WS, Hogan PG & Rao A (1996). Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates the transcription of several cytokine genes. Molecular and Cellular Biology, 16: 3955-3966.
12. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A & Crabtree GR (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature, 369: 497-502.
13. Ho SN, Thomas DJ, Timmerman LA, Li X, Francke U & Crabtree GR (1995). NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. Journal of Biological Chemistry, 270: 19898-19907.
14. Masuda E, Naito Y, Tokumitsu H, Campbell D, Saito F, Hannum C, Arai K-I & Arai N (1995). NFATx, a novel member of the NFAT family that is expressed predominantly in the thymus. Molecular and Cellular Biology, 15: 2697-2706.
15. Crabtree GR & Olson EN (2002). NFAT signaling: choreographing the social lives of cells. Cell, 109 (Suppl): S-67-S-79.
16. Horsley V & Pavlath GK (2002). NFAT: ubiquitous regulator of cell differentiation and adaptation. Journal of Cell Biology, 156: 771-774.
17. Jain J, Burgeon E, Badalian TM, Hogan PG & Rao A (1995). A similar DNA-binding motif in NFAT family proteins and the Rel homology region. Journal of Biological Chemistry, 270: 4138-4145.
18. Shaw KTY, Ho AM, Raghavan A, Kim J, Jain J, Park J, Sharma S, Rao A & Hogan PG (1995). Immunosuppressive drugs prevent a rapid dephosphorylation of the transcription factor NFAT1 in stimulated immune cells. Proceedings of the National Academy of Sciences, USA, 92: 11205-11209.
19. Loh C, Shaw KTY, Carew J, Viola JPB, Luo C, Perrino BA & Rao A (1996). Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. Journal of Biological Chemistry, 271: 10884-10891.
20. Baksh S, DeCaprio JA & Burakoff SJ (2000). Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase. Oncogene, 19: 2820-2827.
21. Iniguez MA, Martinez-Martinez S, Punzon C, Redondo JM & Fresno M (2000). An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. Journal of Biological Chemistry, 275: 23627-23635.
22. Koepp DM, Harper JW & Elledge SJ (1999). How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell, 97: 431-434.
23. Sherr CJ & Roberts JM (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development, 13: 1501-1512.
24. Ren S & Rollins BJ (2004). Cyclin C/Cdk3 promotes Rb-dependent G0 exit. Cell, 117: 239-251.
25. Ohtani K, DeGregori J & Nevins JR (1995). Regulation of the cyclin E gene by transcription factor E2F1. Proceedings of the National Academy of Sciences, USA, 92: 12146-12150.
26. Murray AW (2004). Recycling the cell cycle: cyclins revisited. Cell, 116: 221-234.
27. Anraku Y, Ohya Y & Iida H (1991). Cell cycle control by calcium and calmodulin in Saccharomyces cerevisiae. Biochimica at Biophysica Acta, 1093: 169-177.
28. Tomono M, Toyoshima K, Ito M & Amano H (1996). Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts. Biochemical Journal, 317: 675-680.
29. 2+ signaling and control of growth and proliferation. Biology of the Cell, 96: 55-68.
30. Terada N, Lucas JJ & Gelfand EW (1991). Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. Journal of Immunology, 147: 698-704.
31. Tomono M, Toyoshima K, Ito M, Amano H & Kiss Z (1998). Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Archives of Biochemistry and Biophysics, 363: 374-378.
32. WAF1/CIP1 expression in keratinocyte differentiation. Proceedings of the National Academy of Sciences, USA, 98: 9575-9580.
33. Abbas AK, Murphy KM & Sher A (1996). Functional diversity of helper T lymphocytes. Nature, 383: 787-793.
34. + T cells response: the alternative approaches. Annual Review of Immunology, 15: 297-322.
35. Zheng W & Flavell RA (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell, 89: 587-596.
36. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG & Glimcher LH (2000). A novel transcription factor T-bet directs Th1 lineage commitment. Cell, 100: 655-669.
37. Kaplan MH, Schindler U, Smiley ST & Grusby MJ (1996). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity, 4: 313-319.
38. Kaplan MH, Sun YL, Hoey T & Grusby MJ (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature, 382: 174-177.
39. Rincon M & Flavell RA (1997). T-cell subsets: transcriptional control in the Th1/-Th2 decision. Current Biology, 7: R729-R732.
40. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ & Glimcher LH (1996). Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity, 4: 397-405.
41. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T & Rao A (1996). An enhanced immune response in mice lacking the transcription factor NFAT1. Science, 272: 892-895.
42. Kiani A, Viola JPB, Lichtman AH & Rao A (1997). Downregulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving the transcription factor NFAT1. Immunity, 7: 849-860.
43. Viola JPB, Kiani A, Bozza PT & Rao A (1998). Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: Role of interleukin-4 (IL-4) and IL-5. Blood, 91: 2223-2230.
44. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, Alt FW, Charles de la Brousse F, Hoey T, Grusby M & Glimcher LH (1998). Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity, 8: 125-134.
45. Yoshida H, Nishina H, Takimoto H et al. (1998) The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity, 8: 115-124.
46. Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Gajewski TF, Wang C-R & Reiner SL (1998). Helper T cell differentiation is controlled by the cell cycle. Immunity, 9: 229-237.
47. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW & Locksley RM (2001). Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity, 14: 205-215.
48. Richter A, Löhning M & Radbruch A (1999). Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. Journal of Experimental Medicine, 190: 1439-1450.
49. Ben-Sasson SZ, Gerstel R, Hu-Li J & Paul WE (2001). Cell division is not a "clock" measuring acquisition of competence to produce IFN-γ or IL-4. Journal of Immunology, 166: 112-120.
50. Mullen AC, Hutchins AS, Villarino AV, Lee HW, High FA, Cereb N, Yang SY, Hua X & Reiner SL (2001). Cell cycle controlling the silencing and function of mammalian activators. Current Biology, 11: 1695-1699.
51. Avni O, Lee D, Macian F, Szabo S, Glimcher L & Rao A (2002). Th cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunology, 3: 643-651.
52. Ranger AM, Gerstenfeld LC, Wang J, Kon T, Bae H, Gravallese EM, Glimcher MJ & Glimcher LH (2000). The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. Journal of Experimental Medicine 191: 9-22.
53. Chuvpilo S, Jankevics E, Tyrsin D et al. (2002) Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity, 16: 881-895.
54. Horsley V & Pavlath GK (2003). Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. Journal of Cell Biology, 161: 111-118.
55. Musaro A, McCullagh KJ, Naya FJ, Olson EN & Rosenthal N (1999). IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature, 400: 581-585.
56. Oukka M, Ho IC, De la Brousse FC, Hoey T, Grusby MJ & Glimcher LH (1998). The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity, 9: 295-304.
57. Mosieniak G, Figiel I & Kaminska B (1997). Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. Journal of Neurochemistry, 68: 1142-1149.
58. Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A & Toker A (2002). The role of NFAT transcription factor in integrin-mediated carcinoma invasion. Nature Cell Biology, 4: 540-544.
59. Jiang H, Yamamoto S, Nishikawa K & Kato R (1993). Anti-tumor-promoting action of FK506 a potent immunosuppressive agent. Carcinogenesis, 14: 67-71.
60. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD & Glimcher LH (2000). Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity, 12: 293-300.